Oncoparse is striving to revolutionize the early detection and treatment monitoring of Pancreatic Cancer by developing a cutting-edge bioinformatics pipeline. This pipeline is set to dramatically increase the precision and efficacy of variant calling from non-invasive liquid biopsies.
Company Details
- Employees
- 3
- Address
- Melbourne, 3000, Au
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- https://oncoparse.com/
- Keywords
- PharmSky Research.
- HQ
- Melbourne
Oncoparse Questions
Oncoparse's website is https://oncoparse.com/
Oncoparse's LinkedIn profile is https://au.linkedin.com/company/oncoparse
Oncoparse has
3 employees.
View email and phone details for 3
employees at Oncoparse.
Oncoparse's industry is
Medical and Diagnostic Laboratories
Oncoparse's top competitors are
Oncorevive,
Molecule2market,
Amplia Therapeutics Limited,
Colabs Australia,
Avion,
Lenexa Medical,
Adherium,
Southern Clinical Development Consulting,
Culturon®,
Pharmsky Research.
Oncoparse's categories are Medical and Diagnostic Laboratories
